GENETHON BIOPROD
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

GENETHON BIOPROD Trademark

Serial Number: 79134009 • Registration: 4545774

GENETHON BIOPROD is a trademark filed by GENETHON - Association régie par la loi du 1er juillet 1901 on May 21, 2013. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

GENETHON - Association régie par la loi du 1er juillet 1901

1B rue de l'Internationale
F-91000 Evry , FR

Entity Type: 99

Trademark Details

Filing Date

May 21, 2013

Registration Date

June 10, 2014

Published for Opposition

March 25, 2014

Cancellation Date

May 21, 2023

Goods & Services

Pharmaceutical, veterinary and sanitary products, namely, gene and cell therapy products for the treatment of rare diseases; chemical preparations for medical and pharmaceutical use or for veterinary use, namely, gene and cell therapy products for the treatment of rare diseases; biological preparations for medical and pharmaceutical use or for veterinary use, namely, gene and cell therapy products for the treatment of rare diseases; enzyme preparations for medical and pharmaceutical use or for veterinary use; microorganism cultures for medical and pharmaceutical use or for veterinary use; culture media for bacteriology; nutritive substances for microorganisms for research and development of gene and cell therapy products used in the treatment of rare diseases; preparations of micro-organisms, of genetically modified organisms and of cells for medical and pharmaceutical use or for veterinary use, particularly for gene therapy and cell therapy; compounds acting on genetic or other pathologies, in human beings and animals, particularly on muscle and neuromuscular diseases, diseases of the immune system, cardiovascular diseases, dermatological diseases, diseases of the central and peripheral nervous system, cancers, asthma, allergies, lipid disorders, obesity and diabetes and infectious diseases; kits for preparing cells or for selecting biologically active compounds for medical, biomedical, chemical, genetic, pharmaceutical or veterinary use; diagnostic preparations, reagents and media for medical, biomedical, chemical, genetic, pharmaceutical or veterinary use; diagnostic reagents for in-vitro use in biochemistry, clinical chemistry and microbiology; sanitary preparations for medical use

Pharmaceutical research; research for the discovery of new medicines; scientific research, particularly in the medical, biomedical, chemical, genetic, pharmaceutical or veterinary fields; basic and applied research in the field of gene and cell therapy; technical research in the field of gene and cell therapy; sorting and selection of molecules for use in gene and cell therapy; development and validation of biological tests, cellular tests and genetic tests; activities in functional genomics for identifying, characterizing, validating or developing biologically active molecules; surveying engineering work; technical project study in the field of gene and cell therapy; professional consultancy unrelated to business operations in the field of scientific research and therapies; research and development of new pharmaceutical products for others

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Dec 17, 2023 DENC
DEATH OF INTERNATIONAL REGISTRATION
Dec 17, 2023 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Dec 2, 2023 INNT
GENERIC MADRID TRANSACTION SENT TO IB
Nov 14, 2023 XXSS
GENERIC MADRID TRANSACTION CREATED
Nov 14, 2023 XXCR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Oct 26, 2021 INTR
CANCELLED SECTION 71
Feb 26, 2021 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 10, 2019 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 5, 2014 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 4, 2014 FICS
FINAL DISPOSITION PROCESSED
Nov 4, 2014 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 10, 2014 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 10, 2014 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 25, 2014 NPUB
PUBLISHED FOR OPPOSITION
Mar 25, 2014 PUBO
NOTIFICATION PROCESSED BY IB
Mar 21, 2014 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 5, 2014 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 5, 2014 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 5, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 19, 2014 PREV
ASSIGNED TO LIE
Feb 19, 2014 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 31, 2014 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 31, 2014 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 31, 2014 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 31, 2014 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 31, 2014 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 16, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 16, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 16, 2014 TROA
CORRECTION SENT TO IB
Oct 18, 2013 CRSN
CORRECTION CREATED FOR IB
Oct 18, 2013 CRCR
REFUSAL PROCESSED BY IB
Oct 8, 2013 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 16, 2013 RFCS
REFUSAL PROCESSED BY MPU
Sep 16, 2013 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 13, 2013 RFCR
NON-FINAL ACTION WRITTEN
Sep 12, 2013 CNRT
ASSIGNED TO EXAMINER
Sep 8, 2013 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 16, 2013 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 12, 2013 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 8, 2013 REPR